Antibiotic prophylaxis in dermatologic surgery: updated guidelines.
BACKGROUND
Antibiotic prophylaxis in dermatologic surgery is poorly understood, and data on its use are lacking. Prophylaxis is indicated for the prevention of endocarditis and prosthesis infection, as well as surgical site infection.


OBJECTIVE
We review essential considerations for the use of antibiotic prophylaxis in dermatologic surgery and provide clear guidelines for practical implementation.


METHODS
Guidelines were developed after review of the literature and consultation with infectious disease specialists and subspecialists in the areas of cardiac, orthopedic, and neurosurgical infectious disease at Mayo Clinic.


RESULTS
Three factors affect the decision to use prophylactic antibiotics in dermatologic surgery: (1) the underlying indication for prophylaxis (patient risk stratification), (2) the condition of the skin, and (3) the specific procedure planned. Thorough preoperative evaluation and surgical planning are critical in identifying and optimizing patient and environmental risk factors that may increase the risk of infection. Appropriate antibiotic selections with site-specific consideration and appropriate timing of antibiotic administration are key factors in providing effective prophylaxis.


CONCLUSIONS
Low rates of infection associated with dermatologic surgical procedures warrant selective use of antibiotic prophylaxis. The proposed guidelines reflect current standards of practice.
Maragh
Sherry L
SL
Division of Dermatologic Surgery, Mayo Clinic, Rochester, Minnesota 55905, USA.
Otley
Clark C
CC
Roenigk
Randall K
RK
Phillips
P Kim
PK
D019072:Antibiotic Prophylaxis / Q000592:standards*; D062109:Dermatologic Surgical Procedures; D003880:Dermatology / Q000592:standards*; D006801:Humans